drugset / Trial / NCT02636413

Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance

NCT02636413 ↗

Phase 4 Completed 1 enrolled VenterPharma
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this study is to evaluate both the impact of LacTEST on diagnostic thinking and on patient management, and its reproducibility (Test-Retest), for the diagnosis of hypolactasia in adults and elderly patients presenting with clinical symptoms of lactose intolerance.

Timeline

Start
2015-10
Primary completion
2016-10
Completion
2016-10

Outcome

Met primary endpoint

paper The results proved the noninferiority of the GT compared to the HBT on the impact on diagnostic thinking PMID 30431582 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject gaxilose Diagnostic / imaging agent 0.45 g Oral

Indications